World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
90
Citations
48957
World Ranking
669
National Ranking
312

Medicine

D-Index
90
Citations
48965
World Ranking
11968
National Ranking
6133

Martin Markowitz publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Martin Markowitz sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 191 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Martin Markowitz D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Martin Markowitz sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 90 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Martin Markowitz is affiliated with Rockefeller University in the United States. Their research primarily focuses on the field of Medicine, with a specialization in Infectious Diseases, Emergency Medicine, Hepatology, and Epidemiology.

The scientist's main topics of work include:

  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • HIV-related health complications and treatments
  • Hepatitis C virus research
  • HIV, Drug Use, Sexual Risk

Recent publications by Martin Markowitz feature in prominent medical journals. Notable papers include:

  • Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial, published in 2021 in The Lancet HIV
  • Hepatitis C Virus Reinfection Among Men Who Have Sex With Men With HIV in New York City, published in 2024 in Clinical Infectious Diseases

Frequent co-authors collaborating with Martin Markowitz have included Onyema Ogbuagu, Daniel Podzamczer, David M. Asmuth, Richard Gilson, and Jason Brunetta.

The scientist's contributions are published mainly in the venues:

  • The Lancet HIV
  • Clinical Infectious Diseases

Best Publications

  • Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

    David D. Ho;Avidan U. Neumann;Alan S. Perelson;Wen Chen

  • HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time

    Alan S. Perelson;Avidan U. Neumann;Martin Markowitz;John M. Leonard

  • Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

    Diana Finzi;Monika Hermankova;Theodore Pierson;Lucy M. Carruth

  • Decay characteristics of HIV-1-infected compartments during combination therapy

    Alan S. Perelson;Paulina Essunger;Yunzhen Cao;Mika Vesanen

  • Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.

    G. S. Ogg;Xia Jin;S. Bonhoeffer;P. R. Dunbar

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract.

    Saurabh Mehandru;Michael A. Poles;Michael A. Poles;Klara Tenner-Racz;Amir Horowitz;Amir Horowitz

  • Ordered accumulation of mutations in HIV protease confers resistance to ritonavir.

    Molla A;Korneyeva M;Gao Q;Vasavanonda S

  • Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.

    Linqi Zhang;B. Ramratnam;K. Tenner-Racz;Yuxian He

  • Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.

    Jesus F. Salazar-Gonzalez;Maria G. Salazar;Brandon F. Keele;Gerald H. Learn

  • Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

    Roy T. Steigbigel;David A. Cooper;Princy N. Kumar;Joseph E. Eron

  • HIV-1 drug resistance in newly infected individuals.

    Daniel Boden;Arlene Hurley;Linqi Zhang;Yunzhen Cao

  • Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

    Bonaventura Clotet;Nicholas Bellos;Jean Michel Molina;David Cooper

  • Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.

    David A. Cooper;Roy T. Steigbigel;Jose M. Gatell;Jurgen K. Rockstroh

  • A Preliminary Study of Ritonavir, an Inhibitor of HIV-1 Protease, to Treat HIV-1 Infection

    Markowitz M;Saag M;Powderly Wg;Hurley Am

  • Towards an HIV cure: a global scientific strategy

    Steven G Deeks;Brigitte Autran;Ben Berkhout;Monsef Benkirane

  • Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study.

    Martin Markowitz;Bach-Yen Nguyen;Eduardo Gotuzzo;Fernando Mendo

  • Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis

    Bharat Ramratnam;Sebastian Bonhoeffer;James Binley;Arlene Hurley

  • The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.

    Bharat Ramratnam;John E. Mittler;Linqi Zhang;Daniel Boden

  • Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals.

    Martin Markowitz;Javier O Morales-Ramirez;Bach-Yen Nguyen;Colin M Kovacs

  • Increased Turnover of T Lymphocytes in HIV-1 Infection and Its Reduction by Antiretroviral Therapy

    Hiroshi Mohri;Alan S. Perelson;Keith Tung;Ruy M. Ribeiro

  • A Novel Antiviral Intervention Results in More Accurate Assessment of Human Immunodeficiency Virus Type 1 Replication Dynamics and T-Cell Decay In Vivo

    Martin Markowitz;Michael Louie;Arlene Hurley;Eugene Sun

  • Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy.

    Linqi Zhang;Sharon R. Lewin;Martin Markowitz;Hsi-Hsun Lin

  • Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection.

    Saurabh Mehandru;Michael A Poles;Michael A Poles;Klara Tenner-Racz;Patrick Jean-Pierre

  • DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes

    Leonia Bozzacco;Christine Trumpfheller;Frederick P. Siegal;Saurabh Mehandru

  • High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men.

    Hui-Hui Li;Katharine J. Bar;Shuyi Wang;Julie M. Decker

  • HIV-1 Antigen–specific and –nonspecific B Cell Responses Are Sensitive to Combination Antiretroviral Therapy

    Lynn Morris;James M. Binley;Brian A. Clas;Sebastian Bonhoeffer

  • HIV-1–specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy

    Gabriel M. Ortiz;Douglas F. Nixon;Alexandra Trkola;James Binley

  • Genotypic and Phenotypic Characterization of Human Immunodeficiency Virus Type 1 Variants Isolated from Patients Treated with the Protease Inhibitor Nelfinavir

    A. K. Patick;M. Duran;Y. Cao;D. Shugarts

Frequent Co-Authors

David D. Ho
David D. Ho Columbia University
Arlene Hurley
Arlene Hurley Rockefeller University
Alan S. Perelson
Alan S. Perelson Los Alamos National Laboratory
Saurabh Mehandru
Saurabh Mehandru Icahn School of Medicine at Mount Sinai
Zabrina L. Brumme
Zabrina L. Brumme Simon Fraser University
Bruce D. Walker
Bruce D. Walker Harvard University
Susan J. Little
Susan J. Little University of California, San Diego
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Viviana Simon
Viviana Simon Icahn School of Medicine at Mount Sinai
Chanson J. Brumme
Chanson J. Brumme University of British Columbia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens doors to various related online programs and career options. For those looking for flexible educational opportunities, exploring degrees felons can get is insightful. These programs highlight accessible paths for individuals with diverse backgrounds aiming to enter healthcare and science fields.

One promising career pathway linked to microbiology is becoming a functional medicine nurse practitioner. This role combines scientific knowledge with patient-centered care, making it ideal for those interested in holistic health while leveraging biological expertise.

Alternatively, the healthcare industry also values skills in medical coding, which can be pursued through certified programs. Understanding the details of professional coder certification opens specialized career options that support health data accuracy and management.

For individuals interested in the administrative side of health sciences, careers in health information management are worth considering. Research shows that health information management salary entry-level roles offer competitive pay and growth opportunities, making them a viable pathway following microbiology studies.

Best Scientists Citing Martin Markowitz

Trending Scientists

Recently Published Articles